z-logo
open-access-imgOpen Access
RNA-mediated toxicity in C9orf72 ALS and FTD
Author(s) -
Zachary T. McEachin,
Janani Parameswaran,
Nisha Raj,
Gary J. Bassell,
Jie Jiang
Publication year - 2020
Publication title -
neurobiology of disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.205
H-Index - 166
eISSN - 1095-953X
pISSN - 0969-9961
DOI - 10.1016/j.nbd.2020.105055
Subject(s) - c9orf72 , amyotrophic lateral sclerosis , frontotemporal dementia , trinucleotide repeat expansion , rna , biology , toxicity , mechanism (biology) , frontotemporal lobar degeneration , genetics , gene , disease , medicine , dementia , allele , pathology , philosophy , epistemology
A GGGGCC hexanucleotide repeat expansion in the first intron of C9orf72 is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia. Compelling evidence suggests that gain of toxicity from the bidirectionally transcribed repeat expanded RNAs plays a central role in disease pathogenesis. Two potential mechanisms have been proposed including RNA-mediated toxicity and/or the production of toxic dipeptide repeat proteins. In this review, we focus on the role of RNA mediated toxicity in ALS/FTD caused by the C9orf72 mutation and discuss arguments for and against this mechanism. In addition, we summarize how G4C2 repeat RNAs can elicit toxicity and potential therapeutic strategies to mitigate RNA-mediated toxicity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom